Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Myocardial Infarction
72%
Coronary Artery Disease
66%
ST Segment Elevation Myocardial Infarction
48%
Rapamycin
45%
Coronary Angiography
41%
Diabetes
40%
Drug-Eluting Stent
37%
Atherosclerosis
34%
Atrial Fibrillation
32%
Brain Ischemia
27%
Target Lesion
26%
Coronary Artery
26%
Umirolimus
26%
Primary Percutaneous Coronary Intervention
23%
Revascularization
22%
Acute Coronary Syndrome
21%
Heart Death
21%
Angiography
21%
Vulnerable Plaque
21%
Population
20%
CD34 Antibody
19%
Basic Life Support
19%
Percutaneous Aortic Valve Replacement
19%
Disease
18%
Optical Coherence Tomography
17%
Noncardiac Surgery
17%
Bleeding
16%
Carotid Artery
16%
Cohort Analysis
16%
Diabetes Mellitus
16%
Apoplexy
16%
Fractional Flow Reserve
15%
Antiplatelet
15%
Acute Heart Infarction
13%
Target Lesion Revascularization
13%
Cause of Death
13%
Cardiovascular System
13%
Arteriosclerosis Obliterans
13%
Major Adverse Cardiac Event
13%
Edema
13%
Zotarolimus
13%
Everolimus
13%
Endothelial Progenitor Cell
13%
Cardiac Magnetic Resonance Imaging
13%
Out of Hospital Cardiac Arrest
13%
Defibrillator
13%
Acetylsalicylic Acid
12%
Noninferiority Trial
11%
Thrombosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
80%
Heart Infarction
66%
ST Segment Elevation Myocardial Infarction
52%
Rapamycin
39%
Brain Ischemia
33%
Atrial Fibrillation
32%
CD34 Antibody
26%
Diabetes Mellitus
22%
Disease
20%
Cardiovascular Risk
19%
Umirolimus
19%
Cardiovascular Disease
19%
Heart Death
18%
Cohort Study
16%
Stenosis
13%
Bleeding
13%
Pig
13%
Edema
13%
Observational Study
13%
Acetylsalicylic Acid
12%
Randomized Clinical Trial
9%
Antiplatelet
9%
Noninferiority Trial
9%
Acute Coronary Syndrome
8%
Peripheral Occlusive Artery Disease
8%
Injury
7%
Statin (Protein)
7%
Ischemic Heart Disease
7%
Retrospective Study
7%
Stent Thrombosis
7%
Thromboembolism
7%
Anticoagulant Agent
7%
Aortic Valve Stenosis
6%
Everolimus
6%
Monotherapy
6%
Angina Pectoris
6%
Clopidogrel
6%
Aortic Stenosis
6%
Zotarolimus
6%
Proprotein Convertase 9
6%
Blood Vessel Injury
6%
Cangrelor
6%
Nursing and Health Professions
ST Segment Elevation Myocardial Infarction
26%
Basic Life Support
19%
Heart Infarction
17%
Percutaneous Coronary Intervention
16%
Automated External Defibrillator
13%
CD34 Antibody
13%
Coronary Artery Disease
13%
Confidence Interval
10%
Angiography
8%
Coronary Angiography
8%
Revascularization
7%
Stent
7%
Prophylaxis
7%
Drug Eluting Stent
7%
Heart Death
6%
Acute Coronary Syndrome
6%
Stenosis
6%
Taxonomy
6%
Umirolimus
6%
Rapamycin
6%
Vascular Closure Device
6%
Population
6%
Acute Heart Infarction
6%
Drug Eluting Coronary Stent
6%
Fractional Flow Reserve
6%
Clinical Outcome
6%
Odds Ratio
6%
Resuscitation
6%